2019年10月22日 ASLAN Pharmaceuticals enrolls first patient in proof-of-concept study for ASLAN004 targeting atopic dermatitis
2019年9月30日 ASLAN Pharmaceuticals and Bukwang Pharmaceutical establish a joint venture, JAGUAHR Therapeutics, to develop novel immuno-oncology therapies
2019年9月19日 ASLAN Pharmaceuticals presents late-breaking data from phase 2 study in China testing varlitinib in second line biliary tract cancer at CSCO
2019年9月10日 Abstract on Aslan Pharmaceuticals’ Varlitinib Accepted for Poster Presentation at ESMO Asia Congress 2019
2019年7月31日 ASLAN Pharmaceuticals to present new data on Varlitinib at European Society for Medical Oncology Congress
2019年5月10日 ASLAN Pharmaceuticals’ varlitinib selected by leading Korean gastric cancer group for study in second-line gastric cancer
2019年4月29日 ASLAN Pharmaceuticals reports first quarter 2019 financial results and provides corporate update